These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 17899084)

  • 61. Cell cycle effects of vinflunine, the most recent promising Vinca alkaloid, and its interaction with radiation, in vitro.
    Simoens C; Vermorken JB; Korst AE; Pauwels B; De Pooter CM; Pattyn GG; Lambrechts HA; Breillout F; Lardon F
    Cancer Chemother Pharmacol; 2006 Aug; 58(2):210-8. PubMed ID: 16317558
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The radiosensitising effect of difluorodeoxyuridine, a metabolite of gemcitabine, in vitro.
    Pauwels B; Korst AE; Lambrechts HA; Pattyn GG; de Pooter CM; Lardon F; Vermorken JB
    Cancer Chemother Pharmacol; 2006 Aug; 58(2):219-28. PubMed ID: 16331496
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparative study of the radiosensitizing and cell cycle effects of vinflunine and vinorelbine, in vitro.
    Simoens C; Lardon F; Pauwels B; De Pooter CM; Lambrechts HA; Pattyn GG; Breillout F; Vermorken JB
    BMC Cancer; 2008 Feb; 8():65. PubMed ID: 18312675
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Vinflunine, a novel microtubule inhibitor, suppresses calmodulin interaction with the microtubule-associated protein STOP.
    Makarov AA; Tsvetkov PO; Villard C; Esquieu D; Pourroy B; Fahy J; Braguer D; Peyrot V; Lafitte D
    Biochemistry; 2007 Dec; 46(51):14899-906. PubMed ID: 18052208
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinical activity of vinflunine in transitional cell carcinoma of the urothelium and other solid tumors.
    Bellmunt J; Delgado FM; George C
    Semin Oncol; 2008 Jun; 35(3 Suppl 3):S34-43. PubMed ID: 18538178
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Antitumor activity of vinflunine: effector pathways and potential for synergies.
    Braguer D; Barret JM; McDaid H; Kruczynski A
    Semin Oncol; 2008 Jun; 35(3 Suppl 3):S13-21. PubMed ID: 18538174
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Vinflunine: a new microtubule inhibitor agent.
    Bennouna J; Delord JP; Campone M; Nguyen L
    Clin Cancer Res; 2008 Mar; 14(6):1625-32. PubMed ID: 18347163
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Potential mechanisms of resistance to microtubule inhibitors.
    Kavallaris M; Annereau JP; Barret JM
    Semin Oncol; 2008 Jun; 35(3 Suppl 3):S22-7. PubMed ID: 18538175
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Radiosensitising agents for the radiotherapy of cancer: novel molecularly targeted approaches.
    Dumont F; Altmeyer A; Bischoff P
    Expert Opin Ther Pat; 2009 Jun; 19(6):775-99. PubMed ID: 19456277
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Further mechanistic unravelling of the influence of the cell cycle effects on the radiosensitising mechanism of vinflunine, in vitro.
    Simoens C; Pauwels B; Vermorken JB; Pattyn GG; Lambrechts HA; Breillout F; Lardon F
    Cancer Chemother Pharmacol; 2008 Jul; 62(2):183-93. PubMed ID: 17899084
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Exploring the mechanisms of action of the novel microtubule inhibitor vinflunine.
    Jordan MA; Horwitz SB; Lobert S; Correia JJ
    Semin Oncol; 2008 Jun; 35(3 Suppl 3):S6-S12. PubMed ID: 18538179
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pharmacokinetics, metabolites, and preclinical safety of vinflunine.
    Lobert S; Puozzo C
    Semin Oncol; 2008 Jun; 35(3 Suppl 3):S28-33. PubMed ID: 18538176
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Vinflunine: review of a new vinca alkaloid and its potential role in oncology.
    Ng JS
    J Oncol Pharm Pract; 2011 Sep; 17(3):209-24. PubMed ID: 20584744
    [TBL] [Abstract][Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.